ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE ...

Detailed price information for Promis Neurosciences Inc (PMN-Q) from The Globe and Mail including charting and trades.